Aller au contenu

Publications scientifiques

  • article Ingvarsson J, Grut V, Gustafsson R, Biström M, Lambert L, Michels BE, Bergström T, Flamand L, Waterboer T, Sundström P

    Human herpesvirus 7 and the risk of developing multiple sclerosis

    Brain Commun 8 (1), 2026.

  • article Mulloy RP, Evseev D, Sharlin N, Bui-Marinos MP, Lacasse É and Dubuc I, Flamand L, Corcoran JA

    Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by suppressing antiviral responses

    PLoS Biol 24 (4), 2026.

  • article Blanchette LJ, Bolduc M, Woldemariam T, Yousefi M, Rabezanahary H, Olivera-Ugarte SM, Garneau C, Angers M, Shi R, Flamand L, Baz M, Vidal S, Falzarano D, Lemay JF, Leclerc D

    Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants

    Vaccines (Basel) 14 (4), 2026.

  • article Puhm F, Allaeys I, Petito E, Sang Y, Tupin F, Dos Santos Pereira Andrade A, Doré E, Dubuc I, Vaillancourt M, Dieudé M, Hébert MJ, Florea BI, Trépanier P, Washington VA, Senis Y, Fortin PR, Brisson AR, Wolberg AS, Bury L, Flamand L, Boilard E

    Megakaryocytes Internalize and Are Activated by Immune Complexes

    Circ Res 139 (3), 2026.

  • article Wallace HL, Wight J, Baz M, Dowding B, Flamand L, Hobman T, Jean F, Joy JB, Lang AS, MacParland S, McCormick C, Noyce R, Russell RS, Sagan SM, Snyman J, Rzeszutek GJ, Jafri MS, Bogoch I, Kindrachuk J, Rasmussen AL

    Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April-July 2024): leveraging a newly established pan-Canadian netwo…

    Can J Microbiol 71 2025.

  • article Schultz IC, Dos Santos Pereira Andrade AC, Dubuc I, Laroche A, Allaeys I, Doré E, Bertrand N, Vallières L, Fradette J, Flamand L, Wink MR, Boilard E

    Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19

    Stem Cell Rev Rep 21 (2), 2025.

  • article Dos S P Andrade AC, Lacasse E, Dubuc I, Gudimard L, Gravel A, Puhm F, Campolina-Silva G, Queiroz-Junior C, Allaeys I, Prunier J, Azeggouar Wallen O, Dumais É and Belleannée C, Droit A, Flamand N, Boilard É and Flamand L

    Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection

    Proc Natl Acad Sci U S A 122 (12), 2025.

  • article Lacasse É and Dubuc I, Gudimard L, Andrade ACDSP, Gravel A, Greffard K, Chamberland A, Oger C, Galano JM, Durand T, Philipe É and Blanchet MR, Bilodeau JF, Flamand L

    Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged mice

    Immun Ageing 22 (1), 2025.

  • article Wallace HL, Wight J, Rzeszutek GJ, Jafri MS, Baz M, Dowding B, Flamand L, Hobman T, Jean F, Joy JB, Lang AS, MacParland S, McCormick C, Noyce R, Russell RS, Sagan SM, Snyman J, Bogoch II, Rasmussen AL, Rimoin AW, Kindrachuk J and

    No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024)

    Viral Immunol 38 (6), 2025.

  • article Bayega A, Reiling SJ, Liu JL, Dubuc I, Gravel A, Flamand L, Ragoussis J

    A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method

    Front Genet 16 2025.

  • article Flamand L, Arbuckle J, Bonnafous P, Descamps V, Hill JA, Jarrett R, Jerome K, Kaufer BB, Koide R, Komaroff AL, Medveczky P, Miura H, Mori Y, Parrish N, Pellett PE, Wood M, Yoshikawa T, Zerr DM

    Endogenous human herpesviruses 6A/B

    J Virol 99 (9), 2025.

  • article Bolduc M, Saint-Louis P, Carignan D, Garneau C, Breton Y, Pelletier M, Rancourt A, Satoh MS, Sato S, Gilbert M, Rabezanahary H, Baz M, Dubuc I, Flamand L, Leclerc D

    PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines

    Nanomedicine 71 2026.